Copyright Reports & Markets. All rights reserved.

Global Transcriptome Sequencing Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Transcriptome Sequencing by Type
    • 1.3.1 Overview: Global Transcriptome Sequencing Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Transcriptome Sequencing Consumption Value Market Share by Type in 2025
    • 1.3.3 Coding RNA
    • 1.3.4 Noncoding RNA
  • 1.4 Global Transcriptome Sequencing Market by Application
    • 1.4.1 Overview: Global Transcriptome Sequencing Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Biomedical Field
    • 1.4.3 Non-medical Field
  • 1.5 Global Transcriptome Sequencing Market Size & Forecast
  • 1.6 Global Transcriptome Sequencing Market Size and Forecast by Region
    • 1.6.1 Global Transcriptome Sequencing Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Transcriptome Sequencing Market Size by Region, (2021-2032)
    • 1.6.3 North America Transcriptome Sequencing Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Transcriptome Sequencing Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Transcriptome Sequencing Market Size and Prospect (2021-2032)
    • 1.6.6 South America Transcriptome Sequencing Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Transcriptome Sequencing Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Illumina
    • 2.1.1 Illumina Details
    • 2.1.2 Illumina Major Business
    • 2.1.3 Illumina Transcriptome Sequencing Product and Solutions
    • 2.1.4 Illumina Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Illumina Recent Developments and Future Plans
  • 2.2 Thermo Fisher Scientific
    • 2.2.1 Thermo Fisher Scientific Details
    • 2.2.2 Thermo Fisher Scientific Major Business
    • 2.2.3 Thermo Fisher Scientific Transcriptome Sequencing Product and Solutions
    • 2.2.4 Thermo Fisher Scientific Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.3 Eurofins Scientific
    • 2.3.1 Eurofins Scientific Details
    • 2.3.2 Eurofins Scientific Major Business
    • 2.3.3 Eurofins Scientific Transcriptome Sequencing Product and Solutions
    • 2.3.4 Eurofins Scientific Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Eurofins Scientific Recent Developments and Future Plans
  • 2.4 Roche
    • 2.4.1 Roche Details
    • 2.4.2 Roche Major Business
    • 2.4.3 Roche Transcriptome Sequencing Product and Solutions
    • 2.4.4 Roche Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Roche Recent Developments and Future Plans
  • 2.5 Bio-Rad
    • 2.5.1 Bio-Rad Details
    • 2.5.2 Bio-Rad Major Business
    • 2.5.3 Bio-Rad Transcriptome Sequencing Product and Solutions
    • 2.5.4 Bio-Rad Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Bio-Rad Recent Developments and Future Plans
  • 2.6 Agilent Technologies
    • 2.6.1 Agilent Technologies Details
    • 2.6.2 Agilent Technologies Major Business
    • 2.6.3 Agilent Technologies Transcriptome Sequencing Product and Solutions
    • 2.6.4 Agilent Technologies Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Agilent Technologies Recent Developments and Future Plans
  • 2.7 LabCorp
    • 2.7.1 LabCorp Details
    • 2.7.2 LabCorp Major Business
    • 2.7.3 LabCorp Transcriptome Sequencing Product and Solutions
    • 2.7.4 LabCorp Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 LabCorp Recent Developments and Future Plans
  • 2.8 QIAGEN
    • 2.8.1 QIAGEN Details
    • 2.8.2 QIAGEN Major Business
    • 2.8.3 QIAGEN Transcriptome Sequencing Product and Solutions
    • 2.8.4 QIAGEN Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 QIAGEN Recent Developments and Future Plans
  • 2.9 Pacific Biosciences
    • 2.9.1 Pacific Biosciences Details
    • 2.9.2 Pacific Biosciences Major Business
    • 2.9.3 Pacific Biosciences Transcriptome Sequencing Product and Solutions
    • 2.9.4 Pacific Biosciences Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Pacific Biosciences Recent Developments and Future Plans
  • 2.10 Azenta
    • 2.10.1 Azenta Details
    • 2.10.2 Azenta Major Business
    • 2.10.3 Azenta Transcriptome Sequencing Product and Solutions
    • 2.10.4 Azenta Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Azenta Recent Developments and Future Plans
  • 2.11 BGI Genomics
    • 2.11.1 BGI Genomics Details
    • 2.11.2 BGI Genomics Major Business
    • 2.11.3 BGI Genomics Transcriptome Sequencing Product and Solutions
    • 2.11.4 BGI Genomics Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 BGI Genomics Recent Developments and Future Plans
  • 2.12 Novogene
    • 2.12.1 Novogene Details
    • 2.12.2 Novogene Major Business
    • 2.12.3 Novogene Transcriptome Sequencing Product and Solutions
    • 2.12.4 Novogene Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Novogene Recent Developments and Future Plans
  • 2.13 Macrogen
    • 2.13.1 Macrogen Details
    • 2.13.2 Macrogen Major Business
    • 2.13.3 Macrogen Transcriptome Sequencing Product and Solutions
    • 2.13.4 Macrogen Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Macrogen Recent Developments and Future Plans
  • 2.14 Shanghai ZJ Bio-Tech
    • 2.14.1 Shanghai ZJ Bio-Tech Details
    • 2.14.2 Shanghai ZJ Bio-Tech Major Business
    • 2.14.3 Shanghai ZJ Bio-Tech Transcriptome Sequencing Product and Solutions
    • 2.14.4 Shanghai ZJ Bio-Tech Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Shanghai ZJ Bio-Tech Recent Developments and Future Plans
  • 2.15 Tsingke Biotechnology
    • 2.15.1 Tsingke Biotechnology Details
    • 2.15.2 Tsingke Biotechnology Major Business
    • 2.15.3 Tsingke Biotechnology Transcriptome Sequencing Product and Solutions
    • 2.15.4 Tsingke Biotechnology Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Tsingke Biotechnology Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Transcriptome Sequencing Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Transcriptome Sequencing by Company Revenue
    • 3.2.2 Top 3 Transcriptome Sequencing Players Market Share in 2025
    • 3.2.3 Top 6 Transcriptome Sequencing Players Market Share in 2025
  • 3.3 Transcriptome Sequencing Market: Overall Company Footprint Analysis
    • 3.3.1 Transcriptome Sequencing Market: Region Footprint
    • 3.3.2 Transcriptome Sequencing Market: Company Product Type Footprint
    • 3.3.3 Transcriptome Sequencing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Transcriptome Sequencing Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Transcriptome Sequencing Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Transcriptome Sequencing Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Transcriptome Sequencing Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Transcriptome Sequencing Consumption Value by Type (2021-2032)
  • 6.2 North America Transcriptome Sequencing Market Size by Application (2021-2032)
  • 6.3 North America Transcriptome Sequencing Market Size by Country
    • 6.3.1 North America Transcriptome Sequencing Consumption Value by Country (2021-2032)
    • 6.3.2 United States Transcriptome Sequencing Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Transcriptome Sequencing Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Transcriptome Sequencing Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Transcriptome Sequencing Consumption Value by Type (2021-2032)
  • 7.2 Europe Transcriptome Sequencing Consumption Value by Application (2021-2032)
  • 7.3 Europe Transcriptome Sequencing Market Size by Country
    • 7.3.1 Europe Transcriptome Sequencing Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Transcriptome Sequencing Market Size and Forecast (2021-2032)
    • 7.3.3 France Transcriptome Sequencing Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Transcriptome Sequencing Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Transcriptome Sequencing Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Transcriptome Sequencing Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Transcriptome Sequencing Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Transcriptome Sequencing Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Transcriptome Sequencing Market Size by Region
    • 8.3.1 Asia-Pacific Transcriptome Sequencing Consumption Value by Region (2021-2032)
    • 8.3.2 China Transcriptome Sequencing Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Transcriptome Sequencing Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Transcriptome Sequencing Market Size and Forecast (2021-2032)
    • 8.3.5 India Transcriptome Sequencing Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Transcriptome Sequencing Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Transcriptome Sequencing Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Transcriptome Sequencing Consumption Value by Type (2021-2032)
  • 9.2 South America Transcriptome Sequencing Consumption Value by Application (2021-2032)
  • 9.3 South America Transcriptome Sequencing Market Size by Country
    • 9.3.1 South America Transcriptome Sequencing Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Transcriptome Sequencing Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Transcriptome Sequencing Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Transcriptome Sequencing Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Transcriptome Sequencing Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Transcriptome Sequencing Market Size by Country
    • 10.3.1 Middle East & Africa Transcriptome Sequencing Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Transcriptome Sequencing Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Transcriptome Sequencing Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Transcriptome Sequencing Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Transcriptome Sequencing Market Drivers
  • 11.2 Transcriptome Sequencing Market Restraints
  • 11.3 Transcriptome Sequencing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Transcriptome Sequencing Industry Chain
  • 12.2 Transcriptome Sequencing Upstream Analysis
  • 12.3 Transcriptome Sequencing Midstream Analysis
  • 12.4 Transcriptome Sequencing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Transcriptome Sequencing market size was valued at US$ 2821 million in 2025 and is forecast to a readjusted size of US$ 6923 million by 2032 with a CAGR of 13.8% during review period.
    Transcriptome sequencing employs high-throughput sequencing technologies to get access to almost all transcripts of specific tissues or cells in a certain state by comprehensive and rapid cDNA sequencing, becoming the basis as well as the starting point for the research of gene expression. The main objectives of transcriptome research include the classification of all transcriptional products, the determination of the transcription structure of genes (such as starting sites, 5′ and 3′ terminals, splicing patterns, and post-transcriptional modifications), and the changes in the expression levels of individual transcripts during development. This technology has been widely used in biological research, medical and clinical research, and drug development.
    The key service providers of Transcriptome Sequencing in the world are Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences and Eurofins Scientific, among which the top five providers account for more than 70% of the market share, and Illumina is the largest service provider. The cost of RNA-Seq has decreased significantly over the past decade, making it more accessible to researchers and clinicians. This cost reduction is driven by advancements in sequencing technologies and economies of scale. Transcriptome sequencing is playing a critical role in identifying patient-specific biomarkers and therapeutic targets. The growing focus on precision medicine is driving adoption in oncology, rare diseases, and pharmacogenomics. Increased funding for genomics and transcriptomics research from governments, non-profits, and private investors is supporting market growth. Initiatives like the Cancer Genome Atlas (TCGA) and Human Cell Atlas (HCA) are driving large-scale transcriptome studies.
    This report is a detailed and comprehensive analysis for global Transcriptome Sequencing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Transcriptome Sequencing market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Transcriptome Sequencing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Transcriptome Sequencing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Transcriptome Sequencing market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Transcriptome Sequencing
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Transcriptome Sequencing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Eurofins Scientific, Roche, Bio-Rad, Agilent Technologies, LabCorp, QIAGEN, Pacific Biosciences, Azenta, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Transcriptome Sequencing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Coding RNA
    Noncoding RNA
    Market segment by Application
    Biomedical Field
    Non-medical Field
    Market segment by players, this report covers
    Illumina
    Thermo Fisher Scientific
    Eurofins Scientific
    Roche
    Bio-Rad
    Agilent Technologies
    LabCorp
    QIAGEN
    Pacific Biosciences
    Azenta
    BGI Genomics
    Novogene
    Macrogen
    Shanghai ZJ Bio-Tech
    Tsingke Biotechnology
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Transcriptome Sequencing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Transcriptome Sequencing, with revenue, gross margin, and global market share of Transcriptome Sequencing from 2021 to 2026.
    Chapter 3, the Transcriptome Sequencing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Transcriptome Sequencing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Transcriptome Sequencing.
    Chapter 13, to describe Transcriptome Sequencing research findings and conclusion.

    Buy now